Member States (MS) have 90 days in which to comment on the Rapporteur Member States (RMS) evaluation once it has been placed on CIRCA. After the commenting period, the RMS responds to them, with outstanding issues being taken forward for discussion at a Biocides Technical Meeting.
Once agreement has been reached on a RMS evaluation, the document is updated to include all agreed comments and a draft assessment report is prepared (based on Document I of the RMS evaluation). In parallel, the EU Commission produces a draft decision for inclusion/non-inclusion on to Annex I. The RMS evaluation is then presented to the CA for endorsement, and the draft decision (supported by the assessment report) voted on at a Standing Committee on Biocidal Products (SCBP)
If the active substance is to be included on Annex I of the BPD an Inclusion Directive is then prepared and published in the Official Journal of the European Union, OJEU (formerly the Official Journal of the European Communities – OJEC). This Directive includes the timescales for formal inclusion on to Annex I (when National Regulations cease to apply) and the date by which relevant products need to be authorised. Active substances that have been included on Annex I/IA are listed on the EU Commission website.
For further information on what happens to applications in Europe, see our Europe Page.
Social media
Javascript is required to use HSE website social media functionality.
Follow HSE on Twitter:
Follow @H_S_E